Translational Interfaces of Near-Infrared Photoimmunotherapy: Mechanisms, Devices, and Combinations

Read full text Summarise with VIRAT
Authors: Ryu Okada, Kazuhide Sato
Cited by: 0
References: 37

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Near-infrared photoimmunotherapy (NIR-PIT) converts antibody-antigen binding into highly localized cytotoxicity through 690 nm light activation of an antibody-photoabsorber conjugate (APC).Distinct from photodynamic or photothermal modalities, NIR-PIT operates via photoinduced axial-ligand dissociation of IRDye700DX (IR700), which drives hydrophobic collapse, APC clustering on the plasma membrane, and rapid membrane disruption-termed photochemosis-without generating reactive oxygen species or causing bulk heating.Beyond immediate tumor debulking, NIR-PIT elicits immunogenic cell death (ICD) characterized by calreticulin exposure and ATP/HMGB1 release, and induces the super-enhanced permeability and retention (SUPR) effect that transiently increases intratumoral accumulation of macromolecules and nanodrugs by up to approximately 24-fold in particular in vivo models, compared with the baseline EPR effect.These distinct photochemical and immunological mechanisms provide a strong rationale for combinatorial strategies integrating NIR-PIT with immune checkpoint blockade, cytotoxic chemotherapy, nanomedicine, radiotherapy, and clinically relevant hyperthermia.This review summarizes the mechanistic basis of photochemosis, ICD, and SUPR, and discusses their translational applications, device innovations, and intersections with thermal biology, providing a conceptual framework for advancing photothermalphotoimmunological oncology.

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Photodynamic Therapy Research Studies Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Thermal Medicine
Volume
42
Issue
1
Pages
17–27
Publication date
15 March 2026
Language
EN